New data demonstrates 80% sustained weight loss at three years with the Allurion Program and initial positive outcomes of a novel, generative AI-powered conversational agent for obesity treatment

Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO-EC) held in Vienna, Austria on 2-4 May 2024.

Presentations include data from a survey of 133 patients across seven international obesity centers that shows patients on the Allurion Program lost just over 15% of total body weight at 4 months, and...